The "Pre-Illness" Pivot and Preventative Treatment
In 2026, OTC brands have escaped market stagnation by targeting the "two-day pre-illness window." Consumers are increasingly using wearables to detect early physiological shifts (like HRV drops or slight temperature rises) before symptoms appear.
Incremental Spend: Brands like Kenvue (Zarbee’s) have expanded their portfolios to combine traditional symptom relief with "pre-emptive" immune support.
Longevity Claims: As of 2026, nearly 50% of new dietary supplement SKUs feature at least one "healthspan" or "longevity" claim. NAD+ precursors have officially entered the mainstream OTC market, appearing in 10% of all healthspan-focused product launches.
The "Healthy Beauty" Link: "Looking healthy" is now the top definition of beauty for Gen Z. This has led to a boom in "topical-ingestible" combos—OTC products that pair a skin cream with a matching supplement to treat skin health from the inside out.